Catherine Thompson
About
Catherine Thompson is a scholar working on Urology, Rheumatology and Surgery.
According to data from OpenAlex, Catherine Thompson has authored 33 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Urology, 18 papers in Rheumatology and 8 papers in Surgery. Recurrent topics in Catherine Thompson's work include Pelvic floor disorders treatments (18 papers), Urinary Bladder and Prostate Research (17 papers) and Botulinum Toxin and Related Neurological Disorders (8 papers). Catherine Thompson is often cited by papers focused on Pelvic floor disorders treatments (18 papers), Urinary Bladder and Prostate Research (17 papers) and Botulinum Toxin and Related Neurological Disorders (8 papers). Catherine Thompson collaborates with scholars based in United States, United Kingdom and Canada. Catherine Thompson's co-authors include Cornelia Haag‐Molkenteller, Roger R. Dmochowski, Christopher Nardo, Victor W. Νitti, Wayne Lam, Christopher R. Chapple, Jihao Zhou, Mitchell F. Brin, Karl‐Dietrich Sievert and Peter K. Sand and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and International Journal of Radiation Oncology*Biology*Physics.
In The Last Decade
Catherine Thompson
32 papers receiving 2.2k citations
Hit Papers
Peers
Catherine Thompson
E.H.J. Weil Netherlands
R.A. Janknegt Netherlands
Lysanne Campeau Canada
Giuseppe Brisinda Italy
Rudi A. Janknegt Netherlands
Scott E. Litwiller United States
Paul‐Antoine Lehur France
Samuel Zylstra United States
Federica Cadeddu Italy
C LeReun United Kingdom
Citations per year, relative to Catherine Thompson Catherine Thompson (= 1×)
peers
E.H.J. Weil
Countries citing papers authored by Catherine Thompson
Since
Specialization
Citations
This map shows the geographic impact of Catherine Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Thompson more than expected).
Fields of papers citing papers by Catherine Thompson
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Catherine Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Thompson. The network helps show where Catherine Thompson may publish in the future.
Co-authorship network of co-authors of Catherine Thompson
This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Thompson. A scholar is included among the top collaborators of Catherine Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Thompson. Catherine Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Kennelly, Michael, Francisco Cruz, Sender Herschorn, et al.. (2022). Efficacy and Safety of AbobotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Incontinence Performing Regular Clean Intermittent Catheterization: Pooled Results from Two Phase 3 Randomized Studies (CONTENT1 and CONTENT2). European Urology. 82(2). 223–232.
2.
Weiss, Karl Heinz, et al.. (2021). Comparison of the Pharmacokinetic Profiles of Trientine Tetrahydrochloride and Trientine Dihydrochloride in Healthy Subjects. European Journal of Drug Metabolism and Pharmacokinetics. 46(5). 665–675.
3.
Oleszek, Joyce, Ann Tilton, Nigar Dursun, et al.. (2021). Muscle Selection and Dosing in a Phase 3, Pivotal Study of AbobotulinumtoxinA Injection in Upper Limb Muscles in Children With Cerebral Palsy. Frontiers in Neurology. 12. 728615–728615.
4.
Caffo, Orazio, Catherine Thompson, Maria De Santis, et al.. (2016). Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I–II trials. Radiotherapy and Oncology. 121(2). 193–198.
5.
Thompson, Catherine, Benjamin M. Sanderson, John Logue, et al.. (2016). Tolerability of Concurrent Chemoradiation Therapy With Gemcitabine (GemX), With and Without Prior Neoadjuvant Chemotherapy, in Muscle Invasive Bladder Cancer. International Journal of Radiation Oncology*Biology*Physics. 97(4). 732–739.
6.
Dovedi, Simon J., Catherine Thompson, Jason Kennedy, et al.. (2015). Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer. Annals of Oncology. 27(2). 294–299.
7.
Ginsberg, David A., Francisco Cruz, Sender Herschorn, et al.. (2013). OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology. Advances in Therapy. 30(9). 819–833.
8.
Νitti, Victor W., Karl‐Dietrich Sievert, David Sussman, et al.. (2013). 1367 ONABOTULINUMTOXINA IN PATIENTS WITH OVERACTIVE BLADDER AND URINARY INCONTINENCE: CONSISTENT EFFECT OVER REPEAT TREATMENT. The Journal of Urology. 189(4S).
9.
Chapple, Christopher R., Karl‐Dietrich Sievert, Scott MacDiarmid, et al.. (2013). OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial. European Urology. 64(2). 249–256.
10.
Rovner, Eric, Roger R. Dmochowski, Christopher R. Chapple, et al.. (2013). OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity. Neurourology and Urodynamics. 32(8). 1109–1115.
11.
Kennelly, Michael, Roger R. Dmochowski, Karen Ethans, et al.. (2013). Long-term Efficacy and Safety of OnabotulinumtoxinA in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity: An Interim Analysis. Urology. 81(3). 491–497.
12.
Chapple, Christopher R., Catherine Thompson, Christopher Nardo, Xiaohong Yan, & Cornelia Haag‐Molkenteller. (2012). OnabotulinumtoxinA Significantly Decreases Urinary Incontinence and Provides Treatment Benefit in Patients with Idiopathic Overactive Bladder.
13.
Fowler, Clare J., Stephen M. Auerbach, David A. Ginsberg, et al.. (2012). OnabotulinumtoxinA Improves Health-Related Quality of Life in Patients With Urinary Incontinence Due to Idiopathic Overactive Bladder: A 36-Week, Double-Blind, Placebo-Controlled, Randomized, Dose-Ranging Trial. European Urology. 62(1). 148–157.
14.
Apostolidis, Apostolos, Catherine Thompson, Xiaohong Yan, & Sherif Mourad. (2012). An exploratory, placebo-controlled, dose–response study of the efficacy and safety of onabotulinumtoxinA in spinal cord injury patients with urinary incontinence due to neurogenic detrusor overactivity. World Journal of Urology. 31(6). 1469–1474.
15.
Brubaker, Linda, Angelo E. Gousse, Peter K. Sand, et al.. (2012). Treatment satisfaction and goal attainment with onabotulinumtoxinA in patients with incontinence due to idiopathic OAB. International Urogynecology Journal. 23(8). 1017–1025.
16.
Rovner, Eric, Roger R. Dmochowski, Christopher R. Chapple, et al.. (2011). OnabotulinumtoxinA Improves Urodynamic Outcomes in Patients with Neurogenic Detrusor Overactivity.
17.
Cruz, Francisco, Sender Herschorn, Philip J. Aliotta, et al.. (2011). Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial. European Urology. 60(4). 742–750.
18.
Ginsberg, David A., Angelo E. Gousse, V. Keppenne, et al.. (2011). 1515 PHASE 3 EFFICACY AND SAFETY STUDY OF ONABOTULINUMTOXINA IN PATIENTS WITH URINARY INCONTINENCE DUE TO NEUROGENIC DETRUSOR OVERACTIVITY. The Journal of Urology. 185(4S).
19.
Thompson, Catherine, Tatjana Schilling, Martin Howard, & Paul G. Genever. (2010). SNARE-dependent glutamate release in megakaryocytes. Experimental Hematology. 38(6). 504–515.
20.
Goris, Michael L., et al.. (1994). Modelling the integration of myocardial regional perfusion and function. Nuclear Medicine Communications. 15(1). 9–20???20.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by E.H.J. Weil Breakdown of academic impact, for papers by R.A. Janknegt Breakdown of academic impact, for papers by Lysanne Campeau Breakdown of academic impact, for papers by Giuseppe Brisinda Breakdown of academic impact, for papers by Rudi A. Janknegt Breakdown of academic impact, for papers by Scott E. Litwiller Breakdown of academic impact, for papers by Paul‐Antoine Lehur Breakdown of academic impact, for papers by Samuel Zylstra Breakdown of academic impact, for papers by Federica Cadeddu Breakdown of academic impact, for papers by C LeReun